Education
About Us
Working with TipRanks
Follow Us
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Avadel Pharmaceuticals (AVDL) Ownership Overview
11.36% Insiders
11.35% Mutual Funds
37.49% Other Institutional Investors
8.42% ETFs
31.37% Public Companies and
Individual Investors
The ownership structure of Avadel Pharmaceuticals (AVDL) stock is a mix of institutional, retail, and individual investors. Approximately 57.26% of the company’s stock is owned by Institutional Investors, 11.36% is owned by Insiders, and 31.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 22, 2025 | Linda Palczuk Director | xxxxxxxxxxxxx | $39600 |
| Jan 14, 2025 | Eric J Ende Director | xxxxxxxxxxxxx | $235200 |
| Jan 14, 2025 | Peter Thornton Director | xxxxxxxxxxxxx | $80400 |
| Dec 16, 2024 | xxxxxxxxxxxxx | $24012 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $5274138 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $22839690 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,685,350 | Insider | 6.33% | 47,358,966 | |
| 4,573,029 | Institution | 4.73% | 38,093,332 | |
| 3,716,242 | Insider | 4.10% | 30,956,296 | |
| 3,731,752 | Institution | 3.86% | 31,085,494 | |
| 3,615,989 | Institution | 3.74% | 30,121,188 | |
| 2,813,739 | Institution | 2.91% | 23,438,446 | |
| 2,173,139 | Institution | 2.25% | 18,102,248 | |
| 1,012,850 | Institution | 1.05% | 8,437,041 | |
| 527,891 | Institution | 0.55% | 4,397,332 | |
| 501,821 | Institution | 0.52% | 4,180,169 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,573,029 | Institution | 4.73% | 38,093,332 | |
| 2,813,739 | Institution | 2.91% | 23,438,446 | |
| 1,012,850 | Institution | 1.05% | 8,437,041 | |
| 527,891 | Institution | 0.55% | 4,397,332 | |
| 425,000 | Institution | 0.44% | 3,540,250 | |
| 285,199 | Institution | 0.30% | 2,375,708 | |
| 280,544 | Institution | 0.29% | 2,336,932 | |
| 222,798 | Institution | 0.23% | 1,855,907 | |
| 199,683 | Institution | 0.21% | 1,663,359 | |
| 100,708 | Institution | 0.10% | 838,898 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,836,317 | Institution | 2.94% | 22,435,267 | |
| 2,497,091 | Institution | 2.58% | 20,800,768 | |
| 818,846 | Institution | 0.85% | 6,820,987 | |
| 424,416 | Institution | 0.44% | 3,357,131 | |
| 275,513 | Institution | 0.29% | 2,179,308 | |
| 177,529 | Institution | 0.18% | 1,489,468 | |
| 115,794 | Institution | 0.12% | 964,564 | |
| 101,876 | Institution | 0.11% | 848,627 | |
| 84,705 | Institution | 0.09% | 670,017 | |
| 54,659 | Institution | 0.06% | 458,589 |
FAQ
Who Owns Avadel Pharmaceuticals (AVDL)?
According to the latest TipRanks data, approximately 37.49% of the company's stock is held by institutional investors, 11.36% is held by insiders, and 31.37% is held by retail investors.
What percentage of Avadel Pharmaceuticals (AVDL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.49% of Avadel Pharmaceuticals (AVDL) stock is held by institutional investors.
What percentage of Avadel Pharmaceuticals (AVDL) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.37% of Avadel Pharmaceuticals (AVDL) stock is held by retail investors.
Who owns the most shares of Avadel Pharmaceuticals (AVDL)?
Jeffrey L. Gendell owns the most shares of Avadel Pharmaceuticals (AVDL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.